
LifeStance Insider Sells $492K in Stock, But Analysts See No Red Flags
LifeStance Health director Robert Bessler sold 69,899 shares worth $492,000, retaining over 2.7 million shares. Analysts remain bullish given strong 2025 performance.
LFSTrevenue growthdirector stock sale